Seminars

Search

The purpose of the seminar series component of CDRD's training program is to provide an increased understanding of contemporary drug discovery and development practices, as well as innovations, business development knowledge and a broad range of topics of interest to the pharmaceutical R&D community.

Seminars are typically open to the scientific community. For more information about the CDRD Seminar series, please contact the Training Department.

Upcoming Seminar Dates	Seminar Title	Presenter
Oct 24, 2011	Translational Considerations for the Development of Antibody-Based Therapeutics	Mohammad Tabrizifard

Completed Seminars	Seminar Title	Presenter
Sept 19, 2011	Bridging the Mind-to-Market Gap: PC-TRIADD Approach to Targeting the Molecular Basis of Treatment Resistance in Prostate Cancer	Martin Gleave
May 16, 2011	From Concept to Clinic: A Story of Pain	Simon Pimstone President and CEO, Xenon Pharmaceuticals
April 18, 2011	The Drug Regulatory Approval Process and Key IP and Regulatory Incentives to Innovation in the Drug Industry	Scott Foster, Gowling Lafleur Henderson LLP
March 21, 2011	Economic evaluation and cost-effectiveness analysis: the fourth hurdle in drug development	Larry Lynd, PhD Research Scientist, CHEOS; UBC Director, Collaboration for Outcomes Research and Evaluation, and Assistant Director, Faculty of Pharmaceutical Sciences, UBC
Feb 21, 2011	Innovative Imaging Technologies in Drug Research and Development	Francois Benard, MD Scientific Director, PET Functional Imaging, BCAA
Jan 24, 2011	Parkinson Disease, from Genetics to Novel Therapeutics	Matt Farrer Professor, Department of Medical Genetics, Canada Excellence Research Chair
Nov 15, 2010	Treatment as Prevention: HAART expansion - a powerful strategy to reduce AIDS morbidity and mortality and HIV incidence	Julio Montaner International AIDS Society
Nov 8, 2010	Use of Bionetworks to understand cancer causality: Revisiting cancer drugs	Stephen Friend Sage Bionetworks
Sept 20, 2010	Today's Merck: External Discovery and Preclinical Sciences	Kathleen Metters Merck Frosst
May 17, 2010	British Columbia Proteomics Network: Structure and Activities Novel approaches in quantitative proteomics for companion diagnostics in drug development	Juergen Kast Scientific Director, BC Proteomics Network Christoph Borchers Director, Proteomics Centre, UVic
April 13, 2010	The Devil is in the Details: An Overview on Conducting Successful Clinical Studies	Karole Sutherland Sutherland Consulting Group
March 15, 2010	Considerations for the Development of siRNA Based Drugs (Joint Seminar with the UBC Faculty of Pharmaceutical Sciences)	Ian MacLachlan Tekmira Pharmaceuticals Inc.
January 21, 2010	Chemical Biology of Nuclear Receptors and The Scripps Research Institute Molecular Screening Center	Pat Griffin Professor and Chair, Molecular Therapeutics Director, Translational Research Institute The Scripps Research Institute
January 18, 2010	18 Years in Biotech—A Personal Perspective	Bill Hunter Angiotech Pharmaceuticals Inc.
November 6, 2009	Successful Drug Development in a Small Company Environment	Roger Ulrich Calistoga Pharmaceuticals Inc.
October 19, 2009	Some Thoughts on New Directions for Drug Development	Andrew S. Janoff
April 17, 2009	Can Your Research Discovery Lead to a Drug? The Importance of the Target Product Profile for Researchers	Paul Brennan